Periactin and Zantac drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Periactin (cyproheptadine hydrochloride) and Zantac (ranitidine hydrochloride). Common drug interactions include organ failure among females and cough among males.
The phase IV clinical study analyzes what interactions people have when they take Periactin and Zantac. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.
What is Periactin?
Periactin has active ingredients of cyproheptadine hydrochloride. It is often used in migraine. eHealthMe is studying from 2,214 Periactin users. Check the latest studies of Periactin.
What is Zantac?
Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 434,161 Zantac users. Check the latest studies of Zantac.
79 people who take Periactin and Zantac together, and have interactions are studied.

What are the common drug interactions of Periactin and Zantac, by gender? *:
female:
- Organ failure
- Overdose
- Pruritus (severe itching of the skin)
- Vision blurred
- Cholecystitis chronic (long lasting infection of gallbladder)
- Dehydration (dryness resulting from the removal of water)
- Gastroenteritis (inflammation of stomach and intestine)
- Pulmonary embolism (blockage of the main artery of the lung)
- Abdominal pain
- Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
male:
- Cough
- Constipation
- Vitamin d deficiency
- Pain
- Renal failure (kidney dysfunction)
- Cerebellar ataxia (loss of coordination)
- Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Dysarthria (speech disorder)
- Fall
What are the common drug interactions of Periactin and Zantac, by age (0-1 to 60+)? *:
0-1:
- Acute respiratory failure
- Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
- Coma (state of unconsciousness lasting more than six hours)
- Corona virus infection (infection caused by a corona virus)
- Drug hypersensitivity
- Dyspnoea (difficult or laboured respiration)
- Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
- Influenza
- Pneumonia
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
2-9:
- Diarrhoea
- Drug level increased
- Heart rate increased
- Pyrexia (fever)
- Ventricular extrasystoles (premature cardiac contraction)
- Viral infection
- Weight decreased
- Abdominal pain
- Back pain
- Dehydration (dryness resulting from the removal of water)
10-19:
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Nasal polyps (masses that develop in the lining of the nose)
- Pyrexia (fever)
- Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
- Cough
- Headache (pain in head)
- Abdominal distension
- Abdominal pain upper
- Abnormal behaviour
- Acute respiratory failure
20-29:
- Anxiety
- Asthenia (weakness)
- Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
- Cholecystitis chronic (long lasting infection of gallbladder)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Drug screen positive
- End stage aids
- Haemoglobin decreased
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hepatic lesion
30-39:
- Acidosis (build-up of carbon dioxide in the blood)
- Candiduria (candida in urine)
- Hydronephrosis (water inside the kidney)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Nephrolithiasis (calculi in the kidneys)
- Oedema peripheral (superficial swelling)
- Renal failure (kidney dysfunction)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Staphylococcus test positive
40-49:
- Pruritus (severe itching of the skin)
- Stiff person syndrome
- Urethral pain
- Vaginal burning sensation
- Vaginitis (inflammation of the vagina)
- Cerebellar ataxia (loss of coordination)
- Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Dysarthria (speech disorder)
- Fall
50-59:
- Constipation
- Folliculitis (infection of hair root)
- Headache (pain in head)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Vision blurred
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Femur fracture
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Fracture displacement
- Pain in extremity
60+:
- Nephrolithiasis (calculi in the kidneys)
- Nausea (feeling of having an urge to vomit)
- Lipids increased (excess lipid in body)
- Neuropathy peripheral (surface nerve damage)
- Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Urinary tract infection
- Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Chronic kidney disease
What are the existing conditions these people have? *
- Cystic Fibrosis (disease of the secretary glands): 12 people, 15.19%
- Pain: 12 people, 15.19%
- Hypersensitivity: 12 people, 15.19%
- Stress And Anxiety: 7 people, 8.86%
- Nausea (feeling of having an urge to vomit): 7 people, 8.86%
- High Blood Pressure: 7 people, 8.86%
- Urinary Tract Infection: 5 people, 6.33%
- Depression: 5 people, 6.33%
- Headache (pain in head): 5 people, 6.33%
- High Blood Cholesterol: 5 people, 6.33%
* Approximation only. Some reports may have incomplete information.
Do you take Periactin and Zantac?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Periactin and Zantac:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Periactin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zantac:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Periactin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zantac and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cyproheptadine hydrochloride and ranitidine hydrochloride (the active ingredients of Periactin and Zantac, respectively), and Periactin and Zantac (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Chest Pain - 2 seconds ago
- Paroxysmal Nocturnal Haemoglobinuria and Skin Ulcer - 5 seconds ago
- Oxycodone And Acetaminophen vs. Valium, side effect and effectiveness comparison - 19 seconds ago
- Could Augmentin cause Polycystic Ovary Disease? - 26 seconds ago
- Could Augmentin cause Polyfollicular Ovarian Disease? - 26 seconds ago
- Could Qvar cause Stable Angina? - 46 seconds ago
- Could Ziac cause Hyperkalemia? - 47 seconds ago
- Could Lorazepam cause Weight Decreased? - a minute ago
- Drug interactions of Olanzapine and Nucynta Er - a minute ago
- Tarka vs. Perindopril Erbumine, side effect and effectiveness comparison - a minute ago